Lorcaserin in the Treatment of Cocaine Use Disorder

Completed · Phase 2 · Has a placebo group

Conditions studied: Cocaine-Related Disorders

In brief

The objective of this study is to evaluate the efficacy and safety of lorcaserin in the treatment of cocaine use disorder.

Key facts

Study ID
NCT03007394
Run by
National Institute on Drug Abuse (NIDA)
People needed
272
Starts
2017-12-19
Expected to finish
2019-12-01
Last updated by the study team
2020-08-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.